ROGLIANI, PAOLA
 Distribuzione geografica
Continente #
EU - Europa 253
AS - Asia 248
NA - Nord America 219
AF - Africa 5
OC - Oceania 5
Totale 730
Nazione #
US - Stati Uniti d'America 218
SG - Singapore 186
IE - Irlanda 108
IT - Italia 78
CN - Cina 39
SE - Svezia 30
IN - India 16
AT - Austria 13
FR - Francia 8
CI - Costa d'Avorio 5
DE - Germania 4
AU - Australia 3
ES - Italia 3
JP - Giappone 3
RU - Federazione Russa 3
CH - Svizzera 2
FI - Finlandia 2
HK - Hong Kong 2
NZ - Nuova Zelanda 2
TR - Turchia 2
BG - Bulgaria 1
GB - Regno Unito 1
MX - Messico 1
Totale 730
Città #
Singapore 167
Dublin 108
Boardman 39
Ashburn 33
Beijing 22
Rome 17
Santa Clara 15
Milan 14
Vienna 13
Chicago 12
New York 10
Shanghai 10
Los Angeles 8
Chandler 7
Kolkata 7
Marseille 7
Naples 6
Abidjan 5
Parma 5
Bologna 4
Seattle 4
Visakhapatnam 4
Barcelona 3
Bengaluru 3
Dallas 3
Reggio Emilia 3
Sydney 3
Arlington 2
Bremen 2
Chekhov 2
Fremont 2
Helsinki 2
Istanbul 2
Macerata 2
Miami 2
Osaka 2
Phoenix 2
Sarno 2
Serino 2
St Louis 2
Wan Chai 2
Wellington 2
Zurich 2
Arezzo 1
Aversa 1
Berlin 1
Clifton 1
Guangzhou 1
Gunzenhausen 1
Kochi 1
London 1
Mexico City 1
Palakollu 1
Pune 1
Rutigliano 1
Sofia 1
Turin 1
Totale 578
Nome #
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma 52
Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis 52
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits 47
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score 31
Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis 28
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review 28
An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma 26
A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD 23
Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings 23
Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma 23
Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today? 21
Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models 17
Inflammatory and contractile profile in LPS-challenged equine isolated bronchi: Evidence for IL-6 as a potential target against AHR in equine asthma 17
Beyond Dual Bronchodilation - Triple Therapy, When and Why 17
Asthma and comorbidities: recent advances 17
Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile 16
Letter to the Editor Regarding "Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab" 16
Clinical Interpretation of Efficacy Outcomes in Pharmacological Studies on Triple Fixed-Dose Combination Therapy for Uncontrolled Asthma: Assessment of IRIDIUM and ARGON Studies 15
Dual bronchodilation for the treatment of COPD: From bench to bedside 14
Effects of SARS-CoV-2 Infection on Pulmonary Function Tests and Exercise Tolerance 14
The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review 13
Efficacy of respiratory tele-rehabilitation in COPD patients: Systematic review and meta-analysis 13
Sex differences in adult asthma and COPD therapy: a systematic review 13
Pest sensitization to cockroach, mouse, and rat: An Italian multicenter study 12
Prescribing the right therapy for the treatment of chronic cough: a critical focus on current and investigational options 12
Drug interaction and chronic obstructive respiratory disorders 12
Beclomethasone dipropionate and sodium cromoglycate protect against airway hyperresponsiveness in a human ex vivo model of cow's milk aspiration 12
Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol 11
The discovery and development of gefapixant as a novel antitussive therapy 10
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement 10
Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval 10
The Impact of Thermal Water in Asthma and COPD: A Systematic Review According to the PRISMA Statement 10
Response 9
Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020–2023 9
Systematic literature review of treatments used for refractory or unexplained chronic cough in adults 8
Biologic therapies for chronic obstructive pulmonary disease 8
Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease 7
Doxofylline: Advancing and Empowering Equitable Asthma and COPD Management Beyond Tradition 7
The novel inhaled dual PDE3 and PDE4 inhibitor ensifentrine for the treatment of COPD: A systematic review and meta-analysis protocol on trough FEV1 and exacerbation according to PRISMA statement 7
Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review 7
A comprehensive overview of investigational elastase inhibitors for the treatment of acute respiratory distress syndrome 6
What role will ensifentrine play in the future treatment of chronic obstructive pulmonary disease patients? Implications from recent clinical trials 6
Investigational anti IL-13 asthma treatments: a 2023 update 6
A narrative review on asthma and pest sensitization (cockroach, mouse and rat allergens): a social issue besides the medical problem 6
Biologics for asthma and risk of pneumonia 6
Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPD 5
Use of human airway smooth muscle in vitro and ex vivo to investigate drugs for the treatment of chronic obstructive respiratory disorders 5
Advances in adrenergic receptors for the treatment of chronic obstructive pulmonary disease: 2023 update 5
The future of inhalation therapy in chronic obstructive pulmonary disease 5
An overview of the efficacy and safety of β2-adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease 4
Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences 4
Strength of association between comorbidities and asthma: a meta-analysis 4
Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases 4
Role of exosomes in exacerbations of asthma and COPD: a systematic review 4
Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement 4
Severe Asthma and Biological Therapy: When, Which, and for Whom 4
Can glucagon-like peptide-1 receptor agonists induce asthma? An analysis of the FAERS database 4
Pharmacological Interpretation of the Efficacy of Ensifentrine in Chronic Obstructive Pulmonary Disease: Insights from ENHANCE Trials 4
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review 4
Hyperglycaemia and Chronic Obstructive Pulmonary Disease 2
Totale 789
Categoria #
all - tutte 5.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.793


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023236 0 4 4 4 25 11 30 20 117 11 7 3
2023/2024214 16 20 17 11 14 23 26 16 21 14 8 28
2024/2025339 13 36 137 70 83 0 0 0 0 0 0 0
Totale 789